EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.4.45 | Alzheimer Disease |
31238788 |
PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma. |
causal interaction
unassigned |
3
0 |
| 3.1.4.45 | Brain Injuries, Traumatic |
31238788 |
PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma. |
causal interaction
unassigned |
3
0 |
| 3.1.4.45 | Carcinoma, Hepatocellular |
1648948 |
Elevated carbohydrate phosphotransferase activity in human hepatoma and phosphorylation of cathepsin D. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
3
2
0 |
| 3.1.4.45 | Carcinoma, Hepatocellular |
2176173 |
[Carbohydrate phosphotransferase in human hepatoma and phosphorylation of cathepsin D] |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
3
0 |
| 3.1.4.45 | Genetic Diseases, Inborn |
28306536 |
Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB. |
causal interaction
unassigned |
3
0 |
| 3.1.4.45 | Genetic Diseases, Inborn |
30257828 |
A model of mucopolysaccharidosis type IIIB in pigs. |
causal interaction
unassigned |
4
0 |
| 3.1.4.45 | Hydrocephalus |
14727810 |
Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
2
2
0 |
| 3.1.4.45 | Infections |
30612517 |
Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells. |
unassigned |
0 |
| 3.1.4.45 | Lysosomal Storage Diseases |
29180785 |
Deleting the mouse Hsd17b1 gene results in a hypomorphic Naglu allele and a phenotype mimicking a lysosomal storage disease. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 3.1.4.45 | Lysosomal Storage Diseases |
30408744 |
Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
